- Home
- CCEL vs NDLS Comparison
CCEL vs NDLS Comparison
Compare CCEL & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- NDLS
- Stock Information
- Founded
- CCEL 1989
- NDLS 1995
- Country
- CCEL United States
- NDLS United States
- Employees
- CCEL N/A
- NDLS N/A
- Industry
- CCEL Managed Health Care
- NDLS Restaurants
- Sector
- CCEL Health Care
- NDLS Consumer Discretionary
- Exchange
- CCEL Nasdaq
- NDLS Nasdaq
- Market Cap
- CCEL 36.7M
- NDLS 33.2M
- IPO Year
- CCEL 1997
- NDLS 2013
- Fundamental
- Price
- CCEL $4.72
- NDLS $0.71
- Analyst Decision
- CCEL Strong Buy
- NDLS Buy
- Analyst Count
- CCEL 1
- NDLS 2
- Target Price
- CCEL $8.50
- NDLS $3.00
- AVG Volume (30 Days)
- CCEL 17.6K
- NDLS 220.0K
- Earning Date
- CCEL 10-14-2025
- NDLS 08-13-2025
- Dividend Yield
- CCEL 12.77%
- NDLS N/A
- EPS Growth
- CCEL N/A
- NDLS N/A
- EPS
- CCEL N/A
- NDLS N/A
- Revenue
- CCEL $31,988,783.00
- NDLS $494,752,000.00
- Revenue This Year
- CCEL $1.75
- NDLS $1.19
- Revenue Next Year
- CCEL N/A
- NDLS N/A
- P/E Ratio
- CCEL N/A
- NDLS N/A
- Revenue Growth
- CCEL 1.10
- NDLS N/A
- 52 Week Low
- CCEL $4.09
- NDLS $0.55
- 52 Week High
- CCEL $9.43
- NDLS $1.74
- Technical
- Relative Strength Index (RSI)
- CCEL 51.06
- NDLS 41.34
- Support Level
- CCEL $4.21
- NDLS $0.70
- Resistance Level
- CCEL $4.82
- NDLS $0.76
- Average True Range (ATR)
- CCEL 0.26
- NDLS 0.07
- MACD
- CCEL 0.03
- NDLS -0.01
- Stochastic Oscillator
- CCEL 84.00
- NDLS 9.09
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
About NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.